Press Releases

AMA confronts the rise of nootropics

| 3 Min Read

Responding to the safety concerns generated by a growing personal use of nootropics, physicians at the Annual Meeting of the American Medical Association (AMA) today adopted new policy discouraging the nonmedical use of prescription drugs for cognitive enhancement in healthy individuals.

Nootropics – the so-called smart drugs – include a variety of prescription drugs, supplements, or other substances that claim to improve cognitive functions of healthy individuals, particularly executive function, memory, learning or intelligence.

Full press release available when you sign in

Sign in to the AMA website to get the full version of this press release. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Speech balloons

Physicians must tell their own story—for patients’ sake

| 3 Min Read
Profiles positioned as data points across a map of the U.S.

What tops the state advocacy agenda for doctors in 2026

| 7 Min Read
Supportive group holding hands

Time for decisive action on substance-use disorder treatment

| 5 Min Read
Sitting health care worker in a busy hallway

1 in 3 NPs and PAs switch specialties at least once in career

| 6 Min Read